The scientific community is relentlessly working to investigate and fight SARS-CoV-2. Miltenyi Biotec stands committed to assisting those researchers in getting on top of COVID-19.
SARS-CoV-2 antigens and ACE2
SARS-CoV-2 antigens offer researchers the possibility to investigate virus-specific immune responses, including antigen-specific B cells and antibodies.
All our antigens for SARS-CoV-2 research are available in different filling sizes and with or without biotinylation. Recombinantly expressed antigens are tagged with His and AviTag™. For more details, please visit the respective product pages linked in the table below.
Overview of our antigens for SARS-CoV-2 research
| SARS-CoV-2 lineage | Protein | Sequence part | Production system | Product page |
| n/a | ACE2 | Full length (with CLD) | HEK cells | Recombinant Human ACE2 (HEK) |
| Truncated (w/o CLD) | Insect cells | Recombinant Human ACE2 (insect cells) | ||
| Wild-type variant | Spike protein | Spike trimer (ectodomain) | HEK cells | Recombinant SARS-CoV-2 Spike-Trimer (HEK) |
| Spike monomer (ectodomain) | HEK cells | Recombinant SARS-CoV-2 Spike-Prot (HEK) | ||
| Furin cleavage site (and control) | Chemical synthesis | SARS-CoV-2 Furin Cleavage Site SARS-CoV-2 Furin Cleavage Site Control | ||
| Receptor binding domain (RBD) | HEK cells | Recombinant SARS-CoV-2 RBD (HEK) | ||
| Insect cells | Recombinant SARS-CoV-2 RBD (insect cells) | |||
| S1 | HEK cells | Recombinant SARS-CoV-2 Spike-S1 (HEK) | ||
| S2 | Insect cells | Recombinant SARS-CoV-2 Spike-S2 (insect cells) | ||
| Nucleoprotein | Full length | HEK cells | Recombinant SARS-CoV-2 Nucleoprotein | |
| Envelope protein | C-terminus | Chemical synthesis | SARS-CoV-2 Envelope C-term | |
| N-terminus | Chemical synthesis | SARS-CoV-2 Envelope N-term | ||
| Helical segment 2 (H2) | Chemical synthesis | SARS-CoV-2 Envelope H2 | ||
| Mutated variants | B.1.1.7 (Alpha) spike protein | Spike monomer (ectodomain) | HEK cells | Recombinant SARS-CoV-2 Spike-Prot B.1.1.7 (HEK) |
| Receptor binding domain (RBD) | HEK cells | Recombinant SARS-CoV-2 RBD B.1.1.7 (HEK) | ||
| B.1.351 (Beta) spike protein | Spike monomer (ectodomain) | HEK cells | Recombinant SARS-CoV-2 Spike-Prot B.1.351 (HEK) | |
| Receptor binding domain (RBD) | HEK cells | Recombinant SARS-CoV-2 RBD B.1.351 (HEK) | ||
| B.1.617.2 (Delta) spike protein | Spike monomer (ectodomain) | HEK cells | Recombinant SARS-CoV-2 Spike-Prot B.1.617.2 (HEK) | |
| Receptor binding domain (RBD) | HEK cells | Recombinant SARS-CoV-2 RBD B.1.617.2 (HEK) | ||
| B.1.1.529/BA.1 (Omicron) spike protein | Spike monomer (ectodomain) | HEK cells | Recombinant SARS-CoV-2 Spike-Prot B.1.1.529/BA.1 (HEK) | |
| Receptor binding domain (RBD) | HEK cells | Recombinant SARS-CoV-2 RBD B.1.1.529/BA.1 (HEK) |
Related products:
Find relevant products for analysis, enrichment, and culture of SARS-CoV-2–specific B cells
Are you interested in SARS-CoV-2–specific T cell research? Check out our SARS-CoV-2 PepTivator® Peptide Pools.
Applications of SARS-CoV-2 antigens
- Detection of patient-derived antibodies
- Characterization of patient-specific immune responses
- Detection and phenotyping of virus-specific B cells
- Enrichment of virus-specific B cells
- Analysis of virus binding to host cells
- Protein detection assays
Detection of SARS-CoV-2–specific antibodies in serum samples
Detection of patient-derived antibodies against SARS-CoV-2 antigens via a bead-based immunoassay
Biotinylated recombinant proteins coupled to streptavidin-coated PMMA beads can be applied to detect SARS-CoV-2–specific antibodies in plasmapheresis samples of COVID-19+ patients. The complete protocol can be found here.
Detection of spike protein binding to ACE2
Cell-based assay to analyze the binding of spike protein to native ACE2
The combination of recombinant spike RBD, monomer or trimer, and ACE2-expressing cells can be used to mimic the binding of SARS-CoV-2 to its host cells in vitro. Such binding assays can be applied to study inhibitory/neutralizing effects of components or antibodies.
Furin cleavage screening assay
You have previously chosen International as your location.
What do you want to do?

